eccogene glp-1 Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies Eccogene Announces First Patient Dosed

doi: 10.1007/s40200-024-01472-w, 35

Diet priorities: Should sodium, protein, potassium, or phosphorus change

If they're injured, it helps them healing

To view or add a comment, sign in *GLP-1 Medications: A Potential Breakthrough in Addiction Treatment* GLP-1 receptor agonists, a class of medications commonly used to treat type 2 diabetes and obesity, are being studied for their potential role in addiction treatment and recovery

[DOI] [PubMed] [Google Scholar] 61.McGovern A, Tippu Z, Hinton W, Munro N, Whyte M, de Lusignan S

Saxagliptin but not sitagliptin inhibits CaMKII and PKC via DPP9 inhibition in cardiomyocytes